NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. ("Travere" or "the Company") (NASDAQ:TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TVTX. […]

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AAPL. Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. ("Meta" or "the Company") (NASDAQ:META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/META.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ:URGN). Investors who purchased UroGen securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/URGN.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CAPR.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDAQ:GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/GOCO. Investigation

The acquisition significantly enhances WGI’s transportation capabilities in a vital South Florida market WEST PALM BEACH, FL / ACCESS Newswire / June 2, 2025 / WGI, Inc. (WGI), a nationally recognized design and professional services firm, proudly announces its acquisition of all assets of Miami-based Roadway Design Solutions (RDS), a leading civil engineering consulting firm

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ:SMLR). Investors who purchased Semler securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SMLR. Investigation

As new U.S. tariffs hit medical devices and equipment, raw materials, and essential components, iData Research warns of significant cost escalation and supply disruption across the MedTech sector. A recent U.S. court decision blocking the bulk of the proposed tariffs has only added further uncertainty, leaving manufacturers and suppliers navigating shifting trade policies with little

DXC Technology, a leading Fortune 500 global technology services provider, today announced the relaunch of its DXC Fast RISE with SAP service in Mexico. This initiative gains new momentum following the recent availability of RISE with SAP, now hosted on Microsoft Azure, expanding opportunities to accelerate a cloud-based economy in Mexico through Microsoft's hyperscale datacenter